Dr Kornelia Thomas, MD | |
30 Quaker Farms Rd Ste 1, Southbury, CT 06488 | |
(203) 262-9300 | |
(203) 264-2696 |
Full Name | Dr Kornelia Thomas |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 30 Quaker Farms Rd Ste 1, Southbury, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134500051 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 56040 (Connecticut) | Primary |
Entity Name | Griffin Faculty Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
The Obama administration has rejected Hawaii's proposal to limit most adult Medicaid recipients to 10 days of hospital coverage per year, which would have been the strictest in the nation. Instead, Hawaii has been approved to implement a 30-day hospital coverage limit starting July 1, state and federal health officials say.
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according to a new study published in mBio.
The human nose has millions of olfactory neurons grouped into hundreds of different neuron types. Each of these neuron types expresses only one odorant receptor, and all neurons expressing the same odorant receptor plug into one region in the brain, an organization that allows for specific odors to be sensed.
The elimination of extensive routine preoperative tests and consultations represents an area of potentially large health care savings across many disciplines, particularly for low-risk patients being evaluated for cataract surgery. It is also a major theme of the Choosing Wisely campaign from the American Board of Internal Medicine.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kornelia Thomas, MD 67 Maple Ave Fl 2, Derby, CT 06418-1328 Ph: (203) 732-1330 | Dr Kornelia Thomas, MD 30 Quaker Farms Rd Ste 1, Southbury, CT 06488 Ph: (203) 262-9300 |
News Archive
The Obama administration has rejected Hawaii's proposal to limit most adult Medicaid recipients to 10 days of hospital coverage per year, which would have been the strictest in the nation. Instead, Hawaii has been approved to implement a 30-day hospital coverage limit starting July 1, state and federal health officials say.
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according to a new study published in mBio.
The human nose has millions of olfactory neurons grouped into hundreds of different neuron types. Each of these neuron types expresses only one odorant receptor, and all neurons expressing the same odorant receptor plug into one region in the brain, an organization that allows for specific odors to be sensed.
The elimination of extensive routine preoperative tests and consultations represents an area of potentially large health care savings across many disciplines, particularly for low-risk patients being evaluated for cataract surgery. It is also a major theme of the Choosing Wisely campaign from the American Board of Internal Medicine.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 9 days ago
Dr. Gregory Gerard Decandia, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1461 South Britain Road, Southbury, CT 06488 Phone: 203-586-2000 | |
Dr. Agata Jaskiewicz-poznanska, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Old Waterbury Rd, Southbury, CT 06488 Phone: 203-262-4200 | |
Mrs. Marianne Bette, MD EAAFP Family Medicine Medicare: Medicare Enrolled Practice Location: 77 Main Street North, Southbury, CT 06488 Phone: 203-267-5560 Fax: 203-267-5561 | |
Maria Lementowska, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1461 South Britain Rd, Southbury, CT 06488 Phone: 203-586-2000 Fax: 203-586-2701 | |
Robert Carr, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Old Waterbury Rd, Southbury, CT 06488 Phone: 203-262-4200 | |
Dr. Andrew L Rubman, N.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Main St S, Southbury, CT 06488 Phone: 203-262-6755 |